Significant role of macrophages in human cancers associated with Epstein-Barr virus (Review)
- Authors:
- Misuzu Shimakage
-
Affiliations: Department of Pediatrics, National Hospital Organization, Wakayama National Hospital, Wakayama 644-0044, Japan - Published online on: September 10, 2014 https://doi.org/10.3892/or.2014.3475
- Pages: 1763-1771
This article is mentioned in:
Abstract
 |
|
de Martel, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D and Plummer M: Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 13:607–645. 2012.PubMed/NCBI | |
|
Young LS and Murray PG: Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 22:5108–5121. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Young LS and Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004.PubMed/NCBI | |
|
Shimakage M, Oka T, Shinka T, Kurata A, Sasagawa T and Yutsudo M: Involvement of Epstein-Barr virus expression in testicular tumors. J Urol. 156:253–257. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Labrecque LG, Barnes DM, Fentiman IS and Griffin BE: Epstein-Barr virus in epithelial cell tumors: A breast cancer study. Cancer Res. 55:39–45. 1995.PubMed/NCBI | |
|
Tierney R, Kao K-U, Nagra JK and Rickinson AB: Epstein-Barr virus BamHIW repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for multiple W repeats in wild-type virus strains. J Virol. 85:12363–12375. 2011. | |
|
Allan GJ, Inman GJ, Parker BD, Rowe DT and Farrell PJ: Cell growth effects of Epstein-Barr virus leader protein. J Gen Virol. 73:1547–1551. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Peng RS, Moses SC, Tan J, Kremmer E and Ling PD: The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol. 79:4492–4505. 2005. View Article : Google Scholar | |
|
Shimakage M, Harada S, Kawahara K, Oka T, Yanoma S, Horii K and Sasagawa T: Detection of Epstein-Barr virus nuclear antigen leader protein expression in various human cancers. New Developments in Epstein-Barr Virus Research. Umar S: Nova Science; New York: pp. 261–276. 2006 | |
|
Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y and Kieff E: Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proc Natl Acad Sci USA. 110:18537–18542. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Kurata A, Inoue H, Okamoto Y and Yutsudo M: Tumorigenicity of EBNA2-transfected cells. FEBS Lett. 371:245–248. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H and Inoue M: Epstein-Barr virus (EBV) genes expression in cervical intra-epithelial neoplasia and invasive cervical cancer: A comparative study with human papillomavirus (HPV) infection. Hum Pathol. 31:318–326. 2000. View Article : Google Scholar | |
|
Pan SH, Tai CC, Lin CS, Hsu WB, Chou SF, Lai CC, Chen JY, Tien HF, Lee FY and Wang WB: Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability. Carcinogenesis. 30:366–375. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sano H, Nagata K, Kato K, Kanai K, Yamamoto K, Okuno K, Kuwamoto S, Higashi-Mori H, Sugihara H, Kato M, Murakami I, Kanzaki S and Hayashi K: EBNA-2-deleted Epstein-Barr virus from P3HR1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95–8. Intervirology. 56:114–121. 2013.PubMed/NCBI | |
|
Wu Y, Maruo S, Yajima M, Kanda T and Takada K: Epstein-Barr virus (EBV)-encoded RNA2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J Virol. 81:11236–11245. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rosato P, Anastasiadou E, Garg N, Lenze D, Boccellato F, Vincenti S, Severa M, Coccia EM, Bigi R, Cirone M, Ferretti E, Campese AF, et al: Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. Leukemia. 26:2343–2352. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pfeffer S, Zavolan M, Grasser A, Chien M, Russo J, Ju J, John B, Enright AJ, Marks D, Sander C and Tuschi T: Identification of virus-encoded microRNAs. Science. 304:734–736. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Baichwal VR and Sugden B: Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene. 5:461–467. 1988.PubMed/NCBI | |
|
Zheng H, Li L, Hu D, Deng X and Cao Y: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 4:185–196. 2007.PubMed/NCBI | |
|
Kim K-R, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M and Sato H: Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus LMP1 induces expression of Ets 1 and invasive growth. Oncogene. 19:1764–1771. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shair KH, Bendt KM, Edwards RH, Nielsen JN, Moore DT and Raab-Traub N: Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model. J Virol. 86:5352–5365. 2012. View Article : Google Scholar | |
|
Swaminathan S, Tomkinson B and Kieff E: Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA. 88:1546–1550. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Komano J, Maruo S, Kurozumi K, Oda T and Takada K: Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt’s lymphoma cell line Akata. J Virol. 73:9827–9831. 1999. | |
|
Houmani JL, Davis CI and Ruf IK: Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlates with ribosomal protein L22 binding. J Virol. 83:9844–9853. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Weiss LM and Chen YY: EBER in situ hybridization for Epstein-Barr virus. Meth Mol Biol. 999:223–230. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Sasagawa T, Yoshino K, Yutsudo M, Kimura M, Yamamoto N and Yanoma S: Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinoma. Hum Pathol. 30:3071–3076. 1999. View Article : Google Scholar | |
|
Chatani M, Teshima T, Inoue T, Yoshino K, Ikegami N, Hirai K and Shimakage M: Antibody response against the Epstein-Barr virus-coded nuclear antigen 2 (EBNA2) in nasopharyngeal carcinoma. Laryngoscope. 101:626–629. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Horii K, Tempaku A, Kakudo K, Shirasaka T and Sasagawa T: Association of Epstein-Barr virus with oral cancers. Hum Pathol. 33:608–614. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Kawahara K, Sasagawa T, Inoue H, Yutsudo M, Yoshida A and Yanoma S: Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression. Hum Pathol. 34:1170–1177. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Kawahara K, Harada S, Sasagawa T, Shinka T and Oka T: Expression of Epstein-Barr virus in renal cell carcinoma. Oncol Rep. 18:41–46. 2007.PubMed/NCBI | |
|
Shimakage M and Sasagawa T: Detection of Epstein-Barr virus-determined nuclear antigen-2 mRNA by in situ hybridization. J Virol Meth. 93:23–32. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Dezawa T, Tamura S, Tabata T, Aoyagi N, Koike M, Inoue H, Yutsudo M, Hakura A and Ikegami N: A Ki-1-positive cell line expressing Epstein-Barr virus antigens, established from child with Ki-1-positive lymphoma. Intervirology. 36:215–224. 1993.PubMed/NCBI | |
|
Shimakage M, Nakamine H, Tamura S, Takenaka T, Yutsudo M and Hakura A: Detection of Epstein-Barr virus transcripts in anaplastic large-cell lymphoma by mRNA in situ hybridization. Hum Pathol. 28:1415–1419. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Sasagawa T, Kawahara K, Yutsudo M, Kusuoka H and Kozuka T: Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides. Int J Cancer. 92:226–231. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Nakajima H, Shimakage M, Takeda Y, Furutama D, Sugino M, Kimura F, Shibayama Y and Hanafusa T: Epstein-Barr virus-associated primary leptomeningeal lymphoma. Eur J Neurol. 13:e4–e6. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Sakamaoto H, Harada S, Sasagawa T and Kodama K: Expression of the Epstein-Barr virus in lymphoproliferative diseases of the lung. Oncol Rep. 17:1347–1352. 2007.PubMed/NCBI | |
|
Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K and Sakamaoto H: Expression of Epstein-Barr virus in Langerhans’ cell histiocytosis. Hum Pathol. 35:862–868. 2004. | |
|
Shamaa A, Zyada M, Wagner M, Awad S, Osman MM and Azeem AA: The significance of Epstein-Barr virus (EBV) & DNA topoisomerase II alpha (DNA-topo II alpha) immunoreactivity in normal oral mucosa, oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC). Diagnostic Pathol. 3:45–57. 2008. | |
|
Slots J, Saygun I, Sabeti M and Kubar A: Epstein-Barr virus in oral diseases. J Periodontal Res. 41:235–244. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jalouli J, Lalouli MM, Sapkota D, Ibrahim SO, Larsson PA and Sand L: Human papilloma virus, herpes simplex virus and Epstein-Barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Res. 32:571–580. 2012. | |
|
Szkaradbiewicz A, Kruk-Zagajewska A, Wal M, Jopek M, Wierzbicka A and Kuch A: Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinoma. Clin Exp Med. 2:137–141. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Gonzalez-Moles MA, Gutierrez J, Rodriquez MJ, Ruiz-Avila I and Rodriquez-Archilla A: Epstein-Barr virus latent membrane protein-1 (LMP-1) expression in oral squamous cell carcinoma. Laryngoscope. 112:482–487. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Kobayashi I, Shima K, Saito I, Kiyoshima T, Matsuo K, Ozeki S, Onishi M and Sakai H: Prevalence of Epstein-Barr virus in oral squamous cell carcinoma. J Pathol. 189:34–39. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Herrmann K, Frangou P, Middeldorp J and Niedobitek G: Epstein-Barr virus replication in tongue epithelial cells. J Gen Virol. 83:2995–2998. 2002.PubMed/NCBI | |
|
Frangou P, Buettner M and Niedobitek G: Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands. J Infect Dis. 191:238–242. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Walling DM, Ray AJ, Nichols JE, Flaitz CM and Nichols CM: Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation. J Virol. 81:7249–7268. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kitahara S, Iitaka M, Shimizu T, Serizawa N, Fukasawa N, Miura S, Kawasaki S, Yamanaka K, Kawakami Y, Murakami S, Ishii J and Katayama S: Thyroid involvement by malignant histiocytosis of Langerhans’ cell type. Clin Endocrinol. 45:357–363. 1996. | |
|
Ryder M, Ghossein RA, Ricarte-Filho JCM, Knauf JA and Fagin JA: Increased density of tumor associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer. 15:1069–1074. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Liotti F, Visciano C and Melillo RM: Inflammation in thyroid oncogenes. Am J Cancer Res. 2:286–297. 2012. | |
|
Kim KH, Han EM, Lee ES, Park HS, Kim I and Kim YS: Epstein-Barr virus infection in sarcomatoid renal cell carcinoma tissues. BJU Int. 96:547–552. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Betge J, Pollheimer MJ, Schelemmer A, Hoefler G and Langner C: Gastric cancer and concomitant renal cancer: A systematic immunohistochemical and molecular analysis. Oncol Rep. 26:567–575. 2011.PubMed/NCBI | |
|
Rajpert-De Meyts E, Hørding U, Nielsen HW and Skakkebaek NE: Human papillomavirus and Epstein-Barr virus in the etiology of testicular germ cell tumours. APMIS. 102:38–42. 1994.PubMed/NCBI | |
|
Fend F, Hittmair A, Rogatsch H, Gredler E, Obrist P and Mikuz G: Seminomas positive for Epstein-Barr virus by the polymerase chain reaction: viral RNA transcripts (Epstein-Barr-encoded small RNAs) are present in intratumoral lymphocytes but absent from the neoplastic cells. Mod Pathol. 8:622–625. 1995. | |
|
Arke O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A and Ekbom A: Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer. 82:1–5. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Holl K, Surcel HM, Koskela P, Dillner J, Hallmans G, Wadell G, Kaasila M, Olafsdottir GH, Ogmundsdottir HM, Pukkala E, Stattino P and Lehtinen M: Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case-control study. APMIS. 116:816–822. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Santos NBM, Villanova FE, Andrade PM, Ribalta J, Focchi J, Otsuka AY and Silva ID: Epstein-Barr virus detection in invasive and pre-invasive lesion of the uterine cervix. Oncol Rep. 21:403–405. 2009.PubMed/NCBI | |
|
Kim NR, Lin Z, Kim KR, Cho HY and Kim I: Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri. J Korean Med Sci. 20:636–642. 2005.PubMed/NCBI | |
|
Szostek S, Zawilinska B, Kopec J and Kosz-Vnenchak M: Herpesviruses as possible cofactors in HPV-16-related oncogenesis. Acta Biochimica Pol. 56:337–342. 2009.PubMed/NCBI | |
|
Kuze T, Nakamura N, Hashimoto Y, Abe M and Wakasa H: Clinicopathological, immunological and genetic studies of CD30+ anaplastic large cell lymphoma of B-cell type; association with Epstein-Barr virus in Japanese population. J Pathol. 180:236–242. 1996.PubMed/NCBI | |
|
Tazzari PL, de Totero D, Bolognesi A, Testoni N, Pileri S, Roncella S, Reato G, Stein H, Gobbi M and Stirpe F: An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins. Haematologica. 84:988–995. 1999.PubMed/NCBI | |
|
Agarwal S, Ramanathan U and Naresh KN: Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma. Hum Pathol. 33:146–152. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Noorali S, Pervez S, Yaqoob N, Moatter T, Nasir MI, Haroon S, Hodges E and Smith JL: Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients. Pathol Res Pract. 200:669–679. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YC, Yang WI, Lee MG, Kim SN, Cho KH, Lee SL, Lee MW and Koh JK: Epstein-Barr virus on CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea. Int J Dermatol. 45:1312–1316. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Sasikala PS, Nirmala K, Sundersingh S, Mahli U and Rajkumar T: Frequency and distribution of Epstein-Barr virus infection and its association with p53 expression in a series of primary nodal non-Hodgkin lymphoma patients from South India. Int J Lab Hematol. 32:56–64. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ma L, Katz Y, Sharan KP, Scwarting R and Kim AS: Epstein-Barr virus positive anaplastic large cell lymphoma: myth or reality? Int J Clin Exp Pathol. 4:100–110. 2011.PubMed/NCBI | |
|
Herling M, Rassidakis GZ, Jones D, Schmitt-Graeff A, Sarris AH and Medeiros LJ: Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria. Hum Pathol. 35:455–459. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kasai K, Kon S, Kikuchi K, Sato Y and Kameya T: Expression of carbohydrate antigens, p80NPM/ALK, cytotoxic cell-associated antigens, and Epstein-Barr virus gene products in anaplastic large cell lymphomas. Pathol Int. 48:171–178. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Lopategui JR, Gaffey MJ, Chan JK, Fierson HF, Sun LH, Bellafiore FJ, Chang KL and Weiss LM: Infrequent association of Epstein-Barr virus with CD30-positive anaplastic large cell lymphomas from American and Asian patients. Am J Surg Pathol. 19:42–49. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Hellier I, Dereure O, Segondy M, Guillot B, Baldet P and Guilhou JJ: Unlikely role of Epstein-Barr virus in the pathogenesis of primary cutaneous CD30+ anaplastic large cell lymphoma. Eur J Dermatol. 11:203–208. 2001.PubMed/NCBI | |
|
Park CK and Ko YH: Detection of EBER nuclear RNA in T-cell lymphoma involving the skin - an in situ hybridization study. Br J Dermatol. 134:488–493. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Erkek E, Sahin S, Atakan N, Kokagoz T, Olut A and Goköz A: Examination of mycosis fungoides for the presence of Epstein-Barr virus and human herpesvirus-6 by polymerase chain reaction. J Eur Acad Dermatol Venereol. 15:422–426. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Novelli M, Merlino C, Ponti R, Bergallo M, Quaglino P, Cambien I, Comessatti A, Sidoti F, Costa C, Corino D, Cavallo R, Ponzi AN, Fierro MT and Bernengo MG: Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood. J Invest Dermatol. 129:1556–1561. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Copur MS, Deshpande A, Mleczko K, Norvell M, Hernicek GJ, Woodward S, Frankforter S, Mandolfo N, Fu K and Chan WC: Full clinical recovery after topical treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides. Croat Med J. 46:458–462. 2005.PubMed/NCBI | |
|
Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P, Glorion C, Mansuy L, Gaudelus J, Debre M, Jaubert F, Seigneurin J-M, Thomas C, Joab I, Donadieu J and Geissmann F: Herpesvirus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. PLos One. 3:e32622008. View Article : Google Scholar : PubMed/NCBI | |
|
Csire M, Mikala G, Jako J, Masszi T, Janosi J, Dolgos J, Fule J, Tordai A, Berencsi G and Valyi-Nagy I: Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with Langerhans cell histiocytosis. Pathol Oncol Res. 13:157–160. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sakata N, Toguchi N, Kimura M, Nakayama M, Kawa K and Takemura T: Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection. Pediatr Blood Cancer. 50:924–927. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Feng WH, Bruce I, Raab-Traub N, Busson P and Kenney SC: Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res. 62:1920–1926. 2002.PubMed/NCBI | |
|
Huang J, Chen H, Hutt-Fletcher L, Ambinder F and Hayward SD: Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol. 77:13267–13274. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lee CH, Yeh TH, Lai HC, Wu SY, Su IJ, Takada K and Chang Y: Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytes. J Virol. 85:7333–7342. 2011. View Article : Google Scholar | |
|
Murata T and Tsurumi T: Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency. Front Genet. 4:532013. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Miyata Y, Inoue H, Yutsudo M and Hakura A: Increased sensitivity of EBNA2-transformed rat fibroblasts to ionizing radiation. Int J Cancer. 68:612–615. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Wang ZY, Liu QF, Wang H, Jin J, Wang WH, Wang SL, Song YW, Liu YP, Fang H, Ren H, Wu RY, Chen B, Zhang XM, Lu NN, Zhou LQ and Li YX: Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy. Blood. 10:2003–2010. 2012. View Article : Google Scholar | |
|
Thomas TO, Agrawal P, Guitart J, Rosen ST, Rademaker AW, Querfeld C, Heyes JP, Kuzal TM and Mittal BB: Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Int J Radiat Oncol Biol Phys. 85:747–753. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M, Kimura M, Yanoma S, Ibe M, Yokota S, Tsujino G, Kozuka T, Dezawa T, Tamura S, Ohshima A, Yutsudo M and Hakura A: Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophages. Arch Virol. 144:157–166. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Masy E, Adriaenssens E, Montepellier C, Crepieux P, Mougel A, Quatannens B, Goormachtigh G, Faumont N, Meggetto F, Auriault C, Groux H and Coll J: Human monocytic cell lines transformed in vitro by Epstein-Barr virus type II latency and LMP-1-dependent proliferation. J Virol. 76:6460–6472. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Salek-Ardakani S, Lyons SA and Arrand JR: Epstein-Barr virus promotes human monocyte survival and mutation through a paracrine induction of IFN-alpha. J Immunol. 173:321–331. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tugizov S, Herrara R, Veluppillai P, Greenspan D and Palefsky JM: Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol. 81:5484–5496. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Ikuta K, Sixbey JW and Tibbetts SA: A replication-defective gammaherpesvirus efficiency establishes long-term latency in macrophages but not in B cells in vivo. J Virol. 82:8500–8508. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hwang KK, Chen X, Kozink DM, Gustilo M, Marshall DJ, Whitesides JF, Liao XH, Catera R, Chu CC, Yan XJ, Luftig MA, Haynes GF and Chiorazzi N: Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells. Blood. 119:e35–e44. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Andereesen R, Grugger W, Lohr GW and Bross KJ: Human macrophages can express the Hodgkin’s cell-associated antigen Ki-1 (CD30). Am J Pathol. 134:187–192. 1989. | |
|
Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Qian BZ and Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell. 141:39–50. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Biswas SK and Mantovani A: Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 11:889–896. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Mantovani A: B cells and macrophages in cancer: yin and yang. Nat Med. 17:285–286. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hamada I, Kato M, Yamasaki T, Iwabuchi K, Watanabe T, Yamada T, Itoyama S, Ito H and Okada K: Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. Anticancer Res. 22:4281–4284. 2002.PubMed/NCBI | |
|
Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M and Takeya M: Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 102:1424–1431. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liou P, Bader L, Wang A, Yamashiro D and Kandel J: Correlation of tumor-associated macrophages and clinicopathological factors in Wilms tumor. Vasc Cell. 5:52013. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakage M and Sakamoto H: Macrophage involvement in Epstein-Barr virus-related tumors. Exp Ther Med. 1:285–291. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Thorley-Lawson DA: EBV the prototypical human tumor virus - just how bad is it? J Allergy Clin Immunol. 116:251–261. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, DeVries JE, Roncarolo MG, Mosmann TR and Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci USA. 88:1172–1176. 1991. View Article : Google Scholar | |
|
Miyazakai I, Cheung RK and Dosch H-M: Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med. 178:439–447. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Hsu DH, de Waal Malefyt R, Fierentino DF, Dang MN, Vieira P, DeVries V, Spits H, Mosmann TR and Moore KW: Expression of interkeukin-10 activity by Epstein-Barr virus protein BCRF1. Science. 250:830–832. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Jochum S, Moosmann A, Lang S, Hammerschmidt W and Zeidler R: The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog. 5:e10027042012. View Article : Google Scholar : PubMed/NCBI | |
|
de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Yssel H and de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 174:915–924. 1991. | |
|
Sica A, Allavena P and Mantovani A: Cancer related inflammation: The macrophage connection. Cancer Lett. 264:204–215. 2008. View Article : Google Scholar | |
|
Suzuki T, Tahara H, Narula S, Moore KW, Robbins P and Lotze MT: Viral interleukin 10 (IL-10), the human herpesvirus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med. 182:477–486. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Kanai K, Satoh Y, Yamanaka H, Kawaguchi A, Horie K, Hoshikawa Y, Sata T and Sairenji T: The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates. Virus Genes. 35:563–569. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chao Y, Jing Y, Jia Y, Wang Y, Zhao C and Luo B: Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. J Med Virol. 83:644–650. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JH, Lee GT, Woo SH, Ha YS, Kwon SJ, Kim WJ and Kim IY: BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages. Cancer Res. 73:3604–3614. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ghosh SK, Perrine S and Faller DV: Advances in virus-directed therapeutics against Epstein-Barr virus-associated malignancies. Adv Virol. Mar 5–2012.(Epub ahead of print). View Article : Google Scholar | |
|
Feng WH, Israel B, Raab-Traub N, Busson P and Kenney SC: Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res. 62:1920–1926. 2002.PubMed/NCBI | |
|
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG and Ambinder RF: Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat Med. 14:1118–1122. 2008. View Article : Google Scholar : PubMed/NCBI |
